XDx to Present at the 2008 In Vitro Diagnostic Regulatory and Reimbursement Conference
November, 2008

 

XDx to Present at the Third Annual JMP Securities Healthcare Focus Conference
October, 2008

 

FDA Clears Test to Help Doctors Manage Heart Transplant Patients
August, 2008

 

XDx’s AlloMap^® Gene Expression Test Cleared by U.S. Food and Drug Administration
August, 2008

 

Personalized Medicine Coalition Announces Two New Board Members
July, 2008

 

XDx Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
May, 2008

 

XDx Files Reexamination Request for Source MDx Patent
February, 2008

XDx, Inc. Files Registration Statement for Proposed Initial Public Offering
October, 2007

XDx Sponsors Heart Transplant Recipient and Professional Golfer Erik Compton at The Ultimate Game at Wynn
June, 2007

XDx Presents Recent Success with AlloMap Molecular Expression Testing to International Transplantation Community
April, 2007

XDx and University of Minnesota Establish Lupus Collaboration
February, 2007

XDx to Present at BIO CEO & Investor Conference
February, 2007

Independent Clinical Data Confirms Accuracy of Gene Expression Test for Heart Transplant Patients
January, 2007

XDx to Present at 2007 JP Morgan Healthcare Conference
January, 2007

XDx Announces Appointment of Dr. Mitchell Nelles to Vice President R&D, Technical Operations
January, 2007

Gene Expression Test from XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
October, 2006

XDx Announces Appointment of Dr. James Yee as Chief Medical Officer
August, 2006

XDx Completes $26.5 Million Private Equity Financing
January, 2006

XDx Named 2006 Technology Pioneer by World Economic Forum
December, 2005

XDx Announces Appointment of Vikram Jog as CFO
May, 2005

XDx Launches Noninvasive Test to Enable Better Management of Heart Transplant Patients
April, 2005

XDx Receives CLIA Certification Enabling Launch of AlloMap Testing
November, 2004